Back to Search
Start Over
Patient, industry, and regulatory perspective on antibody-drug conjugates dose optimization.
- Source :
-
Clinical and translational science [Clin Transl Sci] 2024 Mar; Vol. 17 (3), pp. e13759. - Publication Year :
- 2024
- Subjects :
- Humans
Antibodies, Monoclonal
Immunoconjugates
Antineoplastic Agents
Subjects
Details
- Language :
- English
- ISSN :
- 1752-8062
- Volume :
- 17
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Clinical and translational science
- Publication Type :
- Academic Journal
- Accession number :
- 38501292
- Full Text :
- https://doi.org/10.1111/cts.13759